How OpenEvidence Helps Doctors Make Decisions

TL;DR

OpenEvidence helps physicians answer difficult clinical questions at the point of care by searching peer-reviewed medical literature through a specialized AI system. Its free, consumer-style distribution encouraged rapid word-of-mouth adoption, while transparent evidence and publisher partnerships support the accuracy doctors require when evaluating unfamiliar cases, edge conditions, diagnoses, and treatments.

Transcript

one of the things we hear so frequently from doctors about open evidence is you know I used it to look up this thing for a patient case that is maybe a patient case that I would have seen one or two times in my career and then the same doctors are saying that about a different patient case and then about a different patient case and then about a di... Read More

Key Insights

• OpenEvidence is an AI copilot that helps physicians consult peer-reviewed medical literature while making decisions at the point of care. Doctors use it particularly for uncommon patient situations that they may encounter only rarely during their careers, revealing the importance of medicine's long tail.
• The central information problem in medicine is that research expands faster than physicians can realistically read and retain it. Even when attention is limited to influential journals, treatments, evidence, and clinical knowledge continue changing throughout a doctor's career, making efficient access to current literature essential.
• Doctors are consumers as well as members of healthcare organizations. OpenEvidence grew by offering a useful application directly to physicians for free, allowing clinicians to discover it independently and recommend it to colleagues without waiting for organization-wide procurement or deployment decisions.
• Traditional healthcare distribution is slowed by organizational complexity. Selling from the top of a hospital network can involve long intervals between executive meetings, reviews by responsible AI committees, shifting policies, and multiple approval stages before practicing doctors receive any practical benefit.
• Word-of-mouth adoption depends on solving a genuine professional pain point. OpenEvidence spread because physicians found it useful enough to share with other physicians, following a consumer growth model based on product experience rather than elaborate marketing campaigns or large advertising budgets.
• Specialized medical models can outperform large general models for focused clinical applications. OpenEvidence trains smaller systems on peer-reviewed medical literature, narrowing the knowledge environment around the evidence physicians need instead of relying solely on the broad capabilities of general-purpose AI.
• Evidence transparency is fundamental to clinical AI because physicians need to understand the basis of an answer. OpenEvidence emphasizes access to supporting medical literature, allowing doctors to examine relevant evidence rather than treating an AI-generated response as an unsupported conclusion.
• OpenEvidence supports both common institutions and underserved settings by making medical knowledge broadly available to physicians. Its reach includes major medical establishments and small rural practices, where rapid access to specialized research can help clinicians validate edge cases and improve diagnostic reasoning.

Questions & Answers

Q: What is OpenEvidence and how do doctors use it?

OpenEvidence is an AI copilot designed to help physicians access peer-reviewed medical literature at the point of care. Doctors ask it questions connected to patient cases, including unusual conditions or situations they may rarely encounter. The system helps them find relevant evidence, examine possible diagnoses, review treatments, and retrieve information buried within the long tail of medical research.

Q: Why do physicians need an AI tool for medical research?

Physicians face a continuous stream of newly published medical research while also managing demanding clinical workloads. Medical knowledge changes throughout a doctor's career, especially knowledge about available treatments and their effectiveness. OpenEvidence helps address this mismatch by making relevant peer-reviewed information easier to retrieve when a clinical question arises, rather than expecting every doctor to read and remember the entire literature.

Q: How did OpenEvidence gain adoption among doctors?

OpenEvidence treated physicians as individual consumers and made its application freely available instead of beginning with organization-wide hospital sales. Doctors could download the product, use it directly, and recommend it to colleagues when they found it valuable. The company attributes its growth primarily to physician-to-physician word of mouth, driven by practical usefulness rather than a large conventional marketing campaign.

Q: Why did OpenEvidence avoid traditional hospital sales?

Traditional hospital sales can require meetings with several executives, technology leaders, medical officers, and responsible AI committees. Scheduling each stage may take substantial time, while policies, personnel, and organizational strategies can change during the process. OpenEvidence avoided making this the primary route because doctors would receive no immediate benefit while the company waited for multiple institutional reviews and follow-up meetings.

Q: What kinds of clinical questions are well suited to OpenEvidence?

OpenEvidence is especially useful for patient cases that fall within medicine's long tail, including situations a physician may see only rarely during an entire career. Doctors use the system to locate relevant studies, validate edge cases, assess unfamiliar clinical details, and improve diagnostic reasoning. Repeated use across different uncommon cases shows that rare questions collectively represent an important part of clinical work.

Q: Why does OpenEvidence use specialized medical AI models?

OpenEvidence is based on the view that smaller, specialized AI models trained on peer-reviewed medical literature can perform better for medical applications than broad general-purpose models. Specialization focuses the system on sources and questions relevant to physicians. This approach supports clinical usefulness by aligning the model's knowledge environment with published evidence that doctors can consult when making patient-care decisions.

Q: How does OpenEvidence address accuracy and transparency?

OpenEvidence emphasizes peer-reviewed medical literature, supporting evidence, and transparency because unsupported answers are inappropriate for clinical decision-making. Physicians need to examine where information comes from and judge whether it applies to a particular patient. Strategic publisher partnerships, including one with the New England Journal of Medicine, strengthen access to medical content while keeping evidence central to the product's answers.

Q: What does OpenEvidence's growth strategy suggest about healthcare products?

OpenEvidence's experience suggests that healthcare products can spread through consumer-style adoption when they solve an immediate problem for clinicians. Doctors do not need to be treated only as users reached through hospital leadership. A free, useful application can let physicians evaluate the product themselves, receive value quickly, and create organic distribution by recommending it within their professional networks.

Summary & Key Takeaways

• OpenEvidence addresses a central challenge in medicine: physicians cannot continuously absorb the expanding volume of research while caring for patients. The system gives them point-of-care access to peer-reviewed literature, helping them investigate unfamiliar cases, assess potential diagnoses, review treatments, and locate findings that might otherwise remain buried in specialized publications.

• The company avoided the traditional top-down healthcare sales process, which can require repeated meetings with hospital executives and committees before clinicians receive access. Instead, it treated doctors as individual consumers, released a free application, and relied on product usefulness and physician-to-physician recommendations to drive adoption across major institutions, small practices, and rural communities.

• OpenEvidence was built around specialized medical AI rather than a broad general-purpose approach. Its strategy combines models trained on peer-reviewed literature, transparent supporting evidence, and partnerships with publishers such as the New England Journal of Medicine. Accuracy is especially important because physicians use the product to inform real clinical decisions.